You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
High resolution melting for mutation scanning of TP53exons 5–8
|
|---|---|
| Published in |
BMC Cancer, August 2007
|
| DOI | 10.1186/1471-2407-7-168 |
| Pubmed ID | |
| Authors |
Michael Krypuy, Ahmed Ashour Ahmed, Dariush Etemadmoghadam, Sarah J Hyland, Australian Ovarian Cancer Study Group, Anna deFazio, Stephen B Fox, James D Brenton, David D Bowtell, Alexander Dobrovic |
| Abstract |
p53 is commonly inactivated by mutations in the DNA-binding domain in a wide range of cancers. As mutant p53 often influences response to therapy, effective and rapid methods to scan for mutations in TP53 are likely to be of clinical value. We therefore evaluated the use of high resolution melting (HRM) as a rapid mutation scanning tool for TP53 in tumour samples. |
Mendeley readers
The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Denmark | 2 | 2% |
| Turkey | 1 | 1% |
| Latvia | 1 | 1% |
| Canada | 1 | 1% |
| Colombia | 1 | 1% |
| Belgium | 1 | 1% |
| Spain | 1 | 1% |
| Japan | 1 | 1% |
| United States | 1 | 1% |
| Other | 0 | 0% |
| Unknown | 88 | 90% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 22 | 22% |
| Student > Ph. D. Student | 16 | 16% |
| Student > Master | 10 | 10% |
| Professor > Associate Professor | 9 | 9% |
| Student > Bachelor | 6 | 6% |
| Other | 24 | 24% |
| Unknown | 11 | 11% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 42 | 43% |
| Medicine and Dentistry | 25 | 26% |
| Biochemistry, Genetics and Molecular Biology | 10 | 10% |
| Environmental Science | 2 | 2% |
| Business, Management and Accounting | 1 | 1% |
| Other | 5 | 5% |
| Unknown | 13 | 13% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 December 2022.
All research outputs
#7,697,449
of 23,415,749 outputs
Outputs from BMC Cancer
#2,143
of 8,467 outputs
Outputs of similar age
#25,220
of 69,794 outputs
Outputs of similar age from BMC Cancer
#6
of 17 outputs
Altmetric has tracked 23,415,749 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,467 research outputs from this source. They receive a mean Attention Score of 4.4. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 69,794 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.